top
Search terms
Results 1 - 10 of 10 - ordered by :
Ehjournal

The SOCRATES (SOluble guanylate Cyclase stimulatoR in heArT failurE Studies) programme set out to identify one or more preferred doses of vericiguat (Figure 1), to take forward into major outcome ...

European Heart Journal, Cleland, John G.F., Mueller, Christian

Date : 14/04/2017 Item size : 197460 bytes
Ejhf

Association of galectin‐3 and fibrosis markers with long‐term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE‐HF ...

European Journal of Heart Failure, Lopez‐Andrès, Natalia, Rossignol, Patrick, Iraqi, Wafae, Fay, Renaud, Nuée, Josette, Ghio, Stefano, Cleland, John G.F., Zannad, Faiez, Lacolley, Patrick

Date : 01/01/2012 Item size : 199973 bytes
Ejhf

Association of galectin‐3 and fibrosis markers with long‐term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE‐HF ...

European Journal of Heart Failure, Lopez‐Andrès, Natalia, Rossignol, Patrick, Iraqi, Wafae, Fay, Renaud, Nuée, Josette, Ghio, Stefano, Cleland, John G.F., Zannad, Faiez, Lacolley, Patrick

Date : 01/01/2012 Item size : 201292 bytes
Ejhf

Introduction The short-term prognosis of patients with bundle branch block (BBB) following acute myocardial infarction (MI) is poor, but a distinction between right (R) BBB and left (L) BBB is rarely ...

European Journal of Heart Failure, Lewinter, Christian, Torp‐Pedersen, Christian, Cleland, John G.F., Køber, Lars

Date : 01/12/2011 Item size : 155081 bytes
Ejhf

Introduction The short-term prognosis of patients with bundle branch block (BBB) following acute myocardial infarction (MI) is poor, but a distinction between right (R) BBB and left (L) BBB is rarely ...

European Journal of Heart Failure, Lewinter, Christian, Torp‐Pedersen, Christian, Cleland, John G.F., Køber, Lars

Date : 01/12/2011 Item size : 156891 bytes
Ejhf

Introduction In patients with heart failure (HF), pharmacological agents that reduce mortality and morbidity, such as beta-blockers and angiotensin-converting enzyme-inhibitors, also improve geometry ...

European Journal of Heart Failure, Ghio, Stefano, Freemantle, Nick, Scelsi, Laura, Serio, Alessandra, Magrini, Giulia, Pasotti, Michele, Shankar, Aparna, Cleland, John G.F., Tavazzi, Luigi

Date : 01/05/2009 Item size : 167937 bytes
Ejhf

Introduction In patients with heart failure (HF), pharmacological agents that reduce mortality and morbidity, such as beta-blockers and angiotensin-converting enzyme-inhibitors, also improve geometry ...

European Journal of Heart Failure, Ghio, Stefano, Freemantle, Nick, Scelsi, Laura, Serio, Alessandra, Magrini, Giulia, Pasotti, Michele, Shankar, Aparna, Cleland, John G.F., Tavazzi, Luigi

Date : 01/05/2009 Item size : 168012 bytes
Ehjournal

Introduction The overall goal with the treatment of heart failure patients is to improve quality of life and symptoms such as tiredness and dyspnoea, reduce morbidity leading to hospitalization, and ...

European Heart Journal, Wikstrom, Gerhard, Blomström-Lundqvist, Carina, Andren, Bertil, Lönnerholm, Stefan, Blomström, Per, Freemantle, Nick, Remp, Thomas, Cleland, John G.F.

Date : 01/04/2009 Item size : 271790 bytes
Ehjournal

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Aims The CArdiac ...

European Heart Journal, Cleland, John G.F., Daubert, Jean-Claude, Erdmann, Erland, Freemantle, Nick, Gras, Daniel, Kappenberger, Lukas, Tavazzi, Luigi

Date : 01/08/2006 Item size : 205417 bytes
Ehjournal

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Aims The CArdiac ...

European Heart Journal, Cleland, John G.F., Daubert, Jean-Claude, Erdmann, Erland, Freemantle, Nick, Gras, Daniel, Kappenberger, Lukas, Tavazzi, Luigi

Date : 01/08/2006